Animesh D Pardanani

Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis.

Ayalew Tefferi, Z. Estrov, H. Kantarjian, 2010, The New England journal of medicine.

Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report.

Francisco Cervantes, Giovanni Barosi, Juergen Thiele, 2013, Blood.